Recombinant Heme exporter protein D (ccmD)

Shipped with Ice Packs
In Stock

Description

Primary Structure

Recombinant ccmD is a small, single-transmembrane protein with a full-length sequence of 69 amino acids (AA 1–69). Key features include:

  • N-terminal His-tag: Added for purification via affinity chromatography .

  • Transmembrane domain: Anchors the protein in the bacterial membrane, interacting with other ccm complex components .

  • Sequence: MTPAFASWNEFFAMGGYAFFVWLAVVMTVIPLVVLVVHSVMQHRAILRGVAQQRAREARL RAAQQQEAA .

Functional Roles

ccmD operates within the CcmABCD complex, an ATP-dependent heme release system. Key roles include:

  • Stabilizing CcmE: Maintains the integrity of the heme chaperone CcmE in the membrane, ensuring efficient heme transfer to cytochrome c apoproteins .

  • Facilitating Heme Trafficking: Works with CcmABCD to translocate heme from the cytoplasm to the periplasm, where it binds to CcmE .

  • ATP-Dependent Mechanism: Conformational changes driven by ATP hydrolysis in CcmA enable heme release from CcmC to CcmE .

Expression Systems

Recombinant ccmD is primarily produced in E. coli via heterologous expression:

ParameterDetails
HostE. coli BL21 (DE3) or other strains .
TagN-terminal 10xHis-tag for Ni-NTA affinity purification .
Purity>90% (SDS-PAGE) .
StorageLyophilized powder stored at -20°C/-80°C; reconstituted in sterile water .

Functional Studies

  • CcmD Knockout Effects: ΔccmD mutants show reduced holoCcmE levels, indicating a stabilizing role for ccmD in CcmE-membrane association .

  • CcmC Dependency: Overexpression of CcmC compensates for ΔccmA and ΔccmB mutations, bypassing the need for ccmD in holoCcmE formation .

  • Species Variability: Pseudomonas aeruginosa ccmD (UniProt: Q9I3N4) shares conserved structural motifs but differs in experimental applications .

Cytochrome c Biogenesis Studies

  • HoloCcmE Formation: Recombinant ccmD aids in studying the ATP-dependent release of holoCcmE from CcmABCD .

  • Heme Trafficking Assays: Used to investigate the role of ccmD in maintaining heme homeostasis during cytochrome c maturation .

Product Specs

Form
Lyophilized powder
Note: We prioritize shipping the format currently in stock. However, if you have specific format requirements, please indicate them during order placement. We will accommodate your request to the best of our ability.
Lead Time
Delivery time may vary depending on the purchase method and location. For specific delivery times, please consult your local distributor.
Note: All protein shipments are standardly accompanied by blue ice packs. If dry ice packaging is required, please inform us in advance as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. For optimal stability, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial prior to opening to ensure the contents settle to the bottom. Reconstitute the protein with deionized sterile water to a concentration of 0.1-1.0 mg/mL. To optimize long-term storage, we suggest adding 5-50% glycerol (final concentration) and aliquoting the solution for storage at -20°C/-80°C. Our standard glycerol final concentration is 50% and can serve as a reference point.
Shelf Life
The shelf life of our products is influenced by various factors, including storage conditions, buffer composition, storage temperature, and the inherent stability of the protein.
Generally, liquid formulations exhibit a shelf life of 6 months at -20°C/-80°C. Lyophilized forms typically have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store the product at -20°C/-80°C. For multiple uses, aliquoting is necessary. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is established during production. If you have a specific tag type requirement, please inform us, and we will prioritize the development of that tag type.
Synonyms
ccmD; Z3455; ECs3087; Heme exporter protein D; Cytochrome c-type biogenesis protein CcmD
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-69
Protein Length
full length protein
Species
Escherichia coli O157:H7
Target Names
ccmD
Target Protein Sequence
MTPAFASWNEFFAMGGYAFFVWLAVVMTVIPLVVLVVHSVMQHRAILRGVAQQRAREARL RAAQQQEAA
Uniprot No.

Target Background

Function
Heme exporter protein D (CcmD) plays a crucial role in the export of heme to the periplasm, a process essential for the biogenesis of c-type cytochromes.
Database Links

KEGG: ece:Z3455

STRING: 155864.Z3455

Protein Families
CcmD/CycX/HelD family
Subcellular Location
Cell inner membrane; Single-pass membrane protein.

Q&A

What is the precise function of CcmD in bacterial cytochrome c maturation?

CcmD functions as an essential component of the CcmABCD release complex in System I cytochrome c maturation. While CcmD is not required for the initial heme transfer to CcmE, it is absolutely necessary for the subsequent release of holo-CcmE from the CcmABCD complex. Research has demonstrated that in the absence of CcmD, holo-CcmE does not effectively detach from the complex, halting the cytochrome c maturation process . Studies in Escherichia coli have confirmed that CcmD-deficient strains accumulate approximately three times less holo-CcmE than wild-type strains, suggesting that CcmD may also facilitate the "recycling" of components through the heme attachment and release pathway .

Additionally, CcmD has been shown to interact directly with CcmC and to a lesser extent with CcmE through coimmunoprecipitation experiments . The protein appears to serve as an assembly factor that enhances the incorporation of other components into the membrane machinery required for cytochrome c biogenesis.

What is the membrane topology of CcmD and how does it relate to function?

CcmD exhibits a specific membrane topology with the N-terminus oriented in the periplasm and the C-terminus in the cytoplasm, connected by a single transmembrane domain. This topology has been confirmed in both E. coli and Rhodobacter capsulatus . The topology follows the positive-inside/negative-outside rule for membrane protein orientation, with the N-terminal domain (NTD) having a negative charge (at least -1) positioned on the outside of the cytoplasmic membrane, while the C-terminal domain (CTD) contains multiple positive charges consistent with cytoplasmic localization .

This specific orientation appears critical for CcmD's function in releasing holo-CcmE. The periplasmic domain likely mediates protein-protein interactions with the release complex and/or holo-CcmE. A completely conserved GXY motif in the N-terminus has been identified across many CcmD proteins, which may be involved in these release interactions . This structural arrangement allows CcmD to bridge cytoplasmic ATP hydrolysis events with periplasmic heme trafficking processes.

How does CcmD interact with other components of the cytochrome c maturation machinery?

CcmD forms part of the multiprotein CcmABCD complex, with specific interactions that have been characterized through coimmunoprecipitation and affinity purification experiments. Key findings include:

  • CcmD interacts directly with CcmC as demonstrated by coimmunoprecipitation studies

  • When FLAG-tagged at the C-terminus, CcmD copurifies with CcmC-His6

  • Immunoprecipitation with FLAG antibody brings down both GST-CcmA and CcmC-His6, confirming CcmD's incorporation into the complete complex

  • Affinity purification of GST-CcmA on glutathione columns also brings down CcmD-FLAG, further supporting its integration into the CcmABCD complex

These interaction studies reveal that CcmD serves as an integral component of the heme handling machinery rather than an accessory protein. Its association with both the ABC transporter components (CcmA, CcmB) and the heme-handling component (CcmC) suggests it may coordinate activities between these functional modules.

What expression systems are most effective for recombinant CcmD production?

The Escherichia coli strain Nissle 1917 (EcN) has demonstrated superior capabilities for recombinant heme protein production compared to conventional laboratory strains. This superiority extends to the expression of CcmD and other cytochrome c maturation proteins. Key advantages of EcN include:

  • Natural ability to take up heme from the environment through the heme receptor ChuA

  • Higher growth rates during expression, resulting in greater final cell densities (OD578)

  • Ability to incorporate more than twice the amount of heme compared to BL21(DE3) in the absence of additional heme supplementation (RZ = 0.42 vs. 0.19)

  • Capacity for quantitative incorporation of the cofactor when heme is supplied in the growth medium

For comparative purposes, the following table illustrates heme incorporation efficiency across different expression systems:

Expression SystemPurity Value RZ (ASoret band/A280)Relative Heme Content
BL21(DE3) without heme0.1910%
BL21(DE3), heme reconstitution1.74100%
HPEX, heme in culture1.3678%
EcN without heme0.4223%
EcN, heme in culture1.3074%
EcN, heme reconstitution1.3879%
EcN, heme in culture and reconstitution1.6192%

These data demonstrate that EcN provides significant advantages for producing recombinant heme proteins, including CcmD, particularly when coupled with appropriate heme supplementation strategies .

How can researchers optimize heme incorporation when expressing recombinant heme proteins in the cytochrome c maturation pathway?

Several methodologies exist for enhancing heme incorporation during recombinant expression, each with distinct advantages and limitations:

For optimal results in CcmD functional studies, comparative UV-vis and resonance Raman measurements have revealed that the method employed significantly influences heme coordination, with the EcN system representing the most native situation . Researchers should select their approach based on whether structural authenticity or maximum incorporation is the primary objective.

What methodologies can be used to study CcmD-dependent release of holo-CcmE?

The "release assay" has proven particularly valuable for investigating CcmD's role in holo-CcmE release. This methodology involves:

  • Modified CcmE construct: Using a version of CcmE (designated CcmE*) where the endogenous membrane tether is replaced with the cleavable B. pertussis cytochrome c4 signal sequence, resulting in CcmE* expression as a soluble protein in the E. coli periplasm .

  • Fractionation analysis: When the System I cytochrome c maturation system is intact, holo-CcmE* is detected in the periplasmic fraction. When CcmD is absent, no holo-CcmE* is detected in this fraction, even though total CcmE* levels (detected by Western blotting) remain similar .

  • Controls and verification: The assay includes controls to verify that CcmD does not affect the stability or accumulation of CcmE* but is specifically required for its release from the CcmABCD complex .

This methodology has successfully demonstrated that CcmD is essential for the release of holo-CcmE* from the CcmABCD complex, consistent with findings for other components like CcmA (ATP hydrolysis features) and CcmB . The approach allows researchers to distinguish between protein stability effects and specific functional roles in the release process.

How does the conserved GXY motif in CcmD contribute to protein function?

The GXY motif represents a completely conserved sequence feature in the N-terminal domain of CcmD proteins across different bacterial species . While direct experimental characterization of this motif's function remains limited, several important considerations can guide research in this area:

  • Structural significance: The GXY motif is positioned in the periplasmic N-terminal domain of CcmD, consistent with its potential role in protein-protein interactions within the periplasmic space .

  • Conservation pattern: Complete conservation of this motif across diverse bacterial species suggests functional importance. Researchers should consider that while GXY motifs are common in collagen, the function in CcmD likely differs due to its membrane protein context .

  • Experimental approach: Site-directed mutagenesis targeting the conserved glycine and the Y position would be informative. Since CcmD's role in holo-CcmE release has been established, assays measuring this function with GXY motif mutants would directly test the motif's contribution .

  • Protein interaction studies: Pull-down assays with wild-type and mutant variants could identify whether the GXY motif mediates specific interactions with CcmC, CcmE, or other components of the cytochrome c maturation machinery .

Current evidence suggests the GXY motif likely participates in the protein-protein or protein-heme interactions required for the periplasmic release of holo-CcmE, making it an important target for further investigation .

What are the specific roles of histidine residues in the CcmC-CcmD heme transfer system?

Histidine residues play crucial roles in the CcmC component of the CcmC-CcmD heme transfer system. While CcmD itself lacks conserved histidines, its partner protein CcmC contains several histidine residues that are essential for function:

  • Conserved histidines in CcmC: Site-directed mutagenesis studies have demonstrated that conserved histidine residues in CcmC are required for heme transfer to CcmE. Mutation of these histidines inactivates the CcmC protein .

  • Mechanistic significance: The requirement for these histidines supports the hypothesis that CcmC interacts directly with heme, likely through coordination bonds between the histidine imidazole side chains and the heme iron .

  • Functional independence: CcmC appears to be functionally uncoupled from the ABC transporter subunits CcmA and CcmB with respect to heme handling. CcmC is the only Ccm protein strictly required for heme transfer and attachment to CcmE .

  • CcmD's complementary role: While CcmC handles the heme transfer to CcmE through its histidine residues, CcmD complements this function by facilitating the subsequent release of holo-CcmE from the complex, creating a two-step process for heme trafficking .

The experimental evidence indicates that CcmC's histidine residues form the active site for heme binding and transfer, while CcmD functions downstream to facilitate the release of the heme-loaded CcmE . This division of labor enables the precise control of heme trafficking during cytochrome c maturation.

What expression plasmid systems have been validated for recombinant CcmD studies?

Several plasmid systems have been successfully employed for recombinant CcmD expression and functional studies:

  • pASK-based plasmids: Plasmids like pASK-msmS-sGAF2 have been used successfully in EcN for expression of heme proteins related to the cytochrome c maturation system .

  • pGEX fusion systems: The pRGK369 (pGEXCcmABCHisDFLAG) plasmid has been validated for expressing FLAG-tagged CcmD, which remains functional and allows detection with FLAG monoclonal antibodies. This system facilitates co-expression of CcmD with other Ccm proteins and enables affinity purification through the GST:CcmA fusion .

  • pBAD-based expression: Plasmids like pRGK371 (pBADCcmE:6XHis) have been used in conjunction with CcmD expression systems to study the functional relationships between these proteins .

  • pHPEX plasmids: The pHPEX1-pHPEX3 series encodes the outer membrane-bound heme receptor (ChuA) from E. coli O157:H7 and has been validated for enhancing heme content in recombinant heme proteins. These plasmids are particularly useful when studying CcmD in the context of the complete heme incorporation system .

Each of these plasmid systems offers distinct advantages depending on the experimental goals. The pGEX system provides excellent options for protein interaction studies, while pBAD systems offer tight regulation of expression. The pHPEX system specifically addresses heme incorporation challenges, making it valuable for functional studies of the complete cytochrome c maturation system .

How can researchers verify the membrane topology of recombinant CcmD?

Determining the correct membrane topology of CcmD is crucial for understanding its function. Several complementary approaches have been validated:

  • LacZ fusion analysis: Creating fusion proteins between CcmD fragments and β-galactosidase (LacZ) has provided evidence for the N-terminus outside/C-terminus inside topology. In R. capsulatus, a functional CcmD-LacZ fusion that coimmunoprecipitated with CcmA suggested the C-terminal domain is cytoplasmic .

  • Charge distribution analysis: The positive-inside/negative-outside rule for membrane protein topology predicts that the CcmD N-terminal domain (charge of at least -1) is on the outside of the cytoplasmic membrane, while the highly positively charged C-terminal domain resides in the cytoplasm. This computational approach can complement experimental data .

  • Protease accessibility: Limited proteolysis of right-side-out or inside-out membrane vesicles can identify exposed domains. Domains accessible to proteases in right-side-out vesicles are periplasmic, while those accessible in inside-out vesicles are cytoplasmic.

  • Immunofluorescence microscopy: Using antibodies against epitope tags placed at either terminus of CcmD can help determine its orientation when performed on intact versus permeabilized cells.

  • Cysteine labeling: Introducing cysteine residues at various positions and testing their accessibility to membrane-impermeable sulfhydryl reagents can map the topology in detail.

For most comprehensive results, researchers should employ multiple approaches, as each has limitations. The current consensus topology (N-terminus in periplasm, C-terminus in cytoplasm, with one transmembrane domain) is supported by both experimental evidence and computational predictions based on charge distribution .

What are the unresolved questions regarding CcmD's molecular mechanism?

Despite significant advances in understanding CcmD's role in cytochrome c maturation, several critical questions remain unresolved:

  • Specific molecular interactions: While CcmD is known to be part of the CcmABCD complex, the precise molecular interfaces between CcmD and other components remain poorly characterized. How does CcmD structurally interact with CcmC to facilitate holo-CcmE release?

  • Release mechanism: The exact mechanism by which CcmD facilitates the ATP-dependent release of holo-CcmE from the CcmABCD complex remains unclear. Does CcmD undergo conformational changes during this process, and how are these changes coupled to ATP hydrolysis by CcmA?

  • Conserved GXY motif function: The completely conserved GXY motif in the N-terminal domain of CcmD proteins likely plays a role in protein-protein interactions related to holo-CcmE release, but direct experimental evidence for this function is lacking .

  • Signal transduction pathway: How does CcmD communicate between the ATP hydrolysis events in the cytoplasm and the heme handling machinery in the periplasm? The single transmembrane domain must transmit signals across the membrane, but the mechanism remains unknown .

  • Species-specific variations: While CcmD function appears broadly conserved, variations in sequence and potentially in function exist across bacterial species. Understanding these variations could reveal alternative mechanisms or regulatory aspects of CcmD function .

Addressing these questions will require integrated approaches combining structural biology, biochemistry, and genetic analyses to fully elucidate CcmD's contribution to the complex process of cytochrome c maturation.

How might structural determination of CcmD advance cytochrome c maturation research?

Structural determination of CcmD would represent a significant breakthrough for cytochrome c maturation research, with several important implications:

  • Membrane topology validation: A high-resolution structure would definitively resolve the membrane topology of CcmD, confirming the current model of N-terminus outside/C-terminus inside with one transmembrane domain .

  • Interaction interfaces: Structural data would reveal the specific amino acid residues that form the interaction interfaces with CcmC, CcmE, and potentially other components of the cytochrome c maturation machinery .

  • GXY motif characterization: The structure would elucidate the three-dimensional conformation of the conserved GXY motif in the N-terminal domain, providing insights into its functional role in protein-protein interactions .

  • Conformational states: If structures could be obtained in different functional states (e.g., before and after ATP hydrolysis), they might reveal conformational changes that drive the release of holo-CcmE from the complex .

  • Drug development potential: Understanding CcmD structure could facilitate the development of inhibitors targeting cytochrome c maturation in pathogenic bacteria, potentially leading to new antimicrobial strategies .

Technical approaches for structural determination might include X-ray crystallography of the soluble domains, cryo-electron microscopy of the complete CcmABCD complex, or NMR spectroscopy of the individual domains. Each approach presents challenges, particularly given CcmD's small size and membrane association, but would provide invaluable insights into this critical component of the cytochrome c maturation system.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.